MarketCapTrends
PBYI

Puma Biotechnology Inc. (PBYI)

NASDAQ · Healthcare

Puma Biotechnology Inc. annual/quarterly shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Puma Biotechnology Inc. shareholder equity for the quarter ending December 31, 2025 were 130.3M, a 41.48% increase year-over-year.
  • Puma Biotechnology Inc. shareholder equity for 2025 were 130.3M, a 41.48% increase from 2024.
  • Puma Biotechnology Inc. shareholder equity for 2024 were 92.1M, a 72.38% increase from 2023.
  • Puma Biotechnology Inc. shareholder equity for 2023 were 53.4M, a 147.33% increase from 2022.
  • Puma Biotechnology Inc. shareholder equity for 2022 were 21.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Puma Biotechnology Inc. Annual Shareholder Equity (Millions of US $)
2025$130
2024$92
2023$53
2022$22
2021$-2
2020$-6
2019$17
2018$34
2017$53
Puma Biotechnology Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$130
2024-12-31$92
2023-12-31$53
2022-12-31$22
2021-12-31$-2
2020-12-31$-6
2019-12-31$17
2018-12-31$34
2017-12-31$53

Puma Biotechnology Inc. Shareholder Equity — FAQ

Puma Biotechnology Inc. (PBYI) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PBYI's shareholder equity history?

The chart and table above show Puma Biotechnology Inc.'s shareholder equity by year and by quarter, including the growth rate.